NYSE: ANVS
Annovis Bio Inc Stock Ownership - Who owns Annovis Bio?

Insider buying vs selling

Have Annovis Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ANVS insiders and whales buy or sell their stock.

ANVS Shareholders

What type of owners hold Annovis Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael B. Hoffman8.41%1,639,640$2.41MInsider
Marialuisa MacCecchini5.48%1,068,459$1.57MInsider
Vanguard Group Inc2.39%466,277$685.43kInstitution
Citadel Advisors LLC1.10%215,207$316.35kInstitution
Blackrock Inc0.57%111,979$164.61kInstitution
Geode Capital Management LLC0.51%99,564$146.36kInstitution
Merit Financial Group LLC0.51%98,516$144.82kInstitution
Jr Robert M. Whelan0.49%95,700$140.68kInsider
Jane Street Group LLC0.35%68,107$100.12kInstitution
Mark K. White0.31%61,167$89.92kInsider

1 of 3

ANVS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANVS8.09%15.05%
PYPD24.25%0.00%
GBIO63.57%36.43%Net BuyingNet Selling
ALXO73.37%26.63%Net BuyingNet Selling
DOMH5.07%94.93%Net Buying

Annovis Bio Stock Ownership FAQ

Who owns Annovis Bio?

Annovis Bio (NYSE: ANVS) is owned by 8.09% institutional shareholders, 15.05% Annovis Bio insiders, and 76.86% retail investors. Michael B. Hoffman is the largest individual Annovis Bio shareholder, owning 1.64M shares representing 8.41% of the company. Michael B. Hoffman's Annovis Bio shares are currently valued at $2.44M.

If you're new to stock investing, here's how to buy Annovis Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.